Hoechst Pakistan 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Sajjad Iftikhar

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	1.4yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	1.6yrs

최근 관리 업데이트

Recent updates

CEO

Sajjad Iftikhar

1.4yrs

테뉴어

Mr. Sajjad Iftikhar serves as Executive Director at Hoechst Pakistan Limited (formerly known as sanofi-aventis Pakistan Limited) since April 28, 2023 and serves as its Chief Executive Officer since June 30...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Sajjad Iftikhar	CEO & Executive Director	1.6yrs	데이터 없음	데이터 없음
Syed Ali	Non-Executive Director	37.8yrs	데이터 없음	3.32% PKR 722.7m
Syed Ali	Non-Executive Chairman	47.8yrs	데이터 없음	0.0010% PKR 226.7k
Arshad Gohar	Non-Executive Director	13.8yrs	데이터 없음	13.89% PKR 3.0b
Saadia Naveed	Independent Director	1.5yrs	데이터 없음	데이터 없음
Muhammad Burney	Non-Executive Director	1.5yrs	데이터 없음	데이터 없음
Syed Anis Shah	Independent Director	1.6yrs	데이터 없음	데이터 없음
Imtiaz Ahmed Laliwala	Independent Director	7.6yrs	데이터 없음	데이터 없음
Iqra Sajjad	Non-Executive Director	1.2yrs	데이터 없음	데이터 없음

1.6yrs

평균 재임 기간

경험이 풍부한 이사회: HPL 의 이사회는 경험(평균 재직 기간 1.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Hoechst Pakistan 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Hoechst Pakistan Limited Announces Company Secretary Changes

Less than half of directors are independent

sanofi-aventis Pakistan Limited Announces CEO Changes

Sanofi Aventis Pakistan Limited Announces Change of Directors

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: PK₨39.29 (vs PK₨48.68 in 3Q 2023)

Investor sentiment improves as stock rises 16%

Upcoming dividend of PK₨25.00 per share

Now 25% overvalued after recent price rise

Hoechst Pakistan Limited to Report First Half, 2024 Results on Aug 22, 2024

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 17%

Upcoming dividend of PK₨30.00 per share

Hoechst Pakistan Limited Announces Company Secretary Changes

Third quarter 2023 earnings released: EPS: PK₨48.68 (vs PK₨2.50 in 3Q 2022)

Less than half of directors are independent

sanofi-aventis Pakistan Limited Announces CEO Changes

New major risk - Revenue and earnings growth

Full year 2022 earnings released: EPS: PK₨17.29 (vs PK₨93.93 in FY 2021)

Sanofi Aventis Pakistan Limited Announces Change of Directors

Less than half of directors are independent

Investor sentiment deteriorates as stock falls 18%

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: PK₨2.50 (vs PK₨9.81 loss in 3Q 2021)

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: PK₨2.68 loss per share (vs PK₨20.54 profit in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: PK₨22.26 (vs PK₨25.48 in 1Q 2021)

Less than half of directors are independent

Upcoming dividend of PK₨30.00 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: PK₨9.81 loss per share (vs PK₨10.06 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS PK₨20.54 (vs PK₨1.95 loss in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS PK₨25.48 (vs PK₨8.75 loss in 1Q 2020)

Full year 2020 earnings released: EPS PK₨51.12 (vs PK₨16.05 in FY 2019)

Upcoming dividend of PK₨20.00 per share

Full year 2020 earnings released: EPS PK₨51.12 (vs PK₨16.05 in FY 2019)

New 90-day high: PK₨843

New 90-day low: PK₨750

New 90-day low: PK₨779

New 90-day low: PK₨800

CEO

테뉴어

이사회 구성원

평균 재임 기간